Loading...
  • 25mg
  • Other medications (eg order dipyridamole 25mg on-line heart attack young square, a cor- of accumulation to toxic levels and additional renal ticosteroid, methotrexate, a nonsteroidal anti-inflammatory damage. (pili.org)
  • ischemic
  • Dipyridamole is a widely prescribed drug in ischemic disorders, and it is here investigated for potential clinical use as a new treatment for breast cancer. (springer.com)
  • The antihyperglycemic drug metformin and the thrombocyte aggregation inhibitor dipyridamole are often used concomitantly in patients with diabetes who have suffered a transient ischemic attack or stroke. (clinicaltrials.gov)
  • Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A (1987) Different degrees of ischemic threshold stratified by dipyridamole-echocardiography test. (springer.com)
  • cilostazol
  • Acadesine Acetate Barbiturates Benzodiazepines Calcium channel blockers Carbamazepine Carisoprodol Cilostazol Cyclobenzaprine Dilazep Dipyridamole Estradiol Ethanol Flumazenil Hexobendine Hydroxyzine Indomethacin Inosine KF24345 Meprobamate Nitrobenzylthioguanosine Nitrobenzylthioinosine Papaverine Pentoxifylline Phenothiazines Phenytoin Progesterone Propentofylline Propofol Puromycin R75231 RE 102 BS Soluflazine Toyocamycin Tracazolate Tricyclic antidepressants Adenosinergic Reuptake inhibitor SenGupta DJ, Unadkat JD (2004). (wikipedia.org)
  • concomitant
  • Dipyridamole absorption is pH-dependent and concomitant treatment with gastric acid suppressors (such as a proton pump inhibitor) will inhibit the absorption of liquid and plain tablets. (wikipedia.org)
  • Pathways
  • We suggest that when used at appropriate doses and with the correct mode of administration, dipyridamole is a promising agent for breast-cancer treatment, thus also implying its potential use in other cancers that show those highly activated pathways. (springer.com)
  • ischemia
  • In contrast, addition of dipyridamole (DP) to ASA in the European Stroke Prevention Study (ESPS)-2 and the European/Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) reduced the RR of stroke by about 20% compared with ASA alone, without incurring excess bleeding. (ahajournals.org)
  • However, it is not licensed as monotherapy for stroke prophylaxis, although a Cochrane Review suggested that dipyridamole may reduce the risk of further vascular events in patients presenting after cerebral ischemia. (wikipedia.org)
  • reduces
  • Experimental metastasis assays show dipyridamole reduces metastasis formation by 47.5 % in the MDA-MB-231T xenograft model ( p = 0.0122), and by 50.26 % in the 4T1-Luc xenograft model ( p = 0.0292). (springer.com)
  • patients
  • Picano E, Masini M, Lattanzi F, Klassen GA, Distante A, Levantesi D, Marraccini P, L'Abbate A (1988) Short term reproducibility of exercise testing in patients with ST segment elevation and different responses to the dipyridamole test. (springer.com)
  • treatment
  • Treatment with 15 mg/kg/day dipyridamole reduced mean primary tumor size by 67.5 % ( p = 0.0433), while treatment with 30 mg/kg/day dipyridamole resulted in an almost a total reduction in primary tumors ( p = 0.0182). (springer.com)
  • high
  • Lattanzi F, Picano E, Masini M (1988) Safety of high dose dipyridamole echocardiography test. (springer.com)
  • Masini M, Picano E, Lattanzi F, Distante A, L'Abbate (1988) High dose dipyridamole- echocardiography test in women: Correlation with exercise electrocardiography test and coronary angiography. (springer.com)